Jupiter Research Capital (Asia) Ltd’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
Jupiter Research Capital (Asia) Ltd's CLYM Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Climb Bio (CLYM) in Q3 2026: 21,158 shares worth $243K. The stake represents 0.03% of the portfolio and ranks #547 among its holdings.
125 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 21,158 shares of Climb Bio worth $243K as of Q3 2026.
- Climb Bio was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Climb Bio made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #547 holding.
- 125 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.